key: cord-0932496-p99iq2xk
authors: Riad, Abanoub; Gomaa, Esraa; Hockova, Barbora; Klugar, Miloslav
title: Oral candidiasis of COVID‐19 patients: Case report and review of evidence
date: 2021-03-21
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14066
sha: 4ab2ca940f3655a29913ef8561463f0ed8e6d975
doc_id: 932496
cord_uid: p99iq2xk

The immune dysregulation triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been hypothesised as a causal pathway for the increasingly reported oral manifestations associated with coronavirus diseases (COVID-19) especially the ones of fungal origin.1-3 As a result of this, we aim to report according to the CARE guidelines, three COVID-19 cases who sought teleconsultations from our private practice (Cairo, Egypt) from July to September 2020. In addition, we have performed a literature search in Ovid MEDLINE®, EMBASE, Cochrane Library, and Epistemonikos from inception until November 30th , 2020 with a combination of keywords (COVID-19 OR SARS-CoV-2) AND oral candidiasis.

A 70-year-old female patient with a history of geriatric depression, peripheral neuropathy, urinary incontinence, chronic constipation, and vascular disease had sought a teleconsultation on September 15, 2020, due to severe burning sensation and dysphagia. Twenty days earlier, the patient started to suffer from diarrhea with no apparent underlying cause; therefore, she had been admitted to the hospital after confirming her SARS-CoV-2 infection through polymerase chain reaction (PCR) testing. During her 15-day stay at the primary care, the patient was given azithromycin (Zithromax), levofloxacin (Uniloxam), rivaroxaban (Xarelto), and lactoferrin (Pravotin). After her respiratory and gastrointestinal symptoms were controlled, the patient was released from the hospital and sent for home isolation, although her PCR result remained positive. 

A previously healthy 25-year-old female dentist was quarantined because SARS-CoV-2 conformingly infected some members of her household. A few days later, the patient started to feel fatigue, headache, anosmia, and ageusia; therefore, she was instructed to follow a medical protocol composed of moxifloxacin, pantoprazole (Zurcal), and multivitamins. Two weeks after losing taste and smell, the patient had a severe burning sensation, and she immediately sought a teleconsultation and sent us her intra-oral images 

A 56-year-old female patient with a history of diabetes mellitus type 2 and rheumatoid arthritis had sought a teleconsultation due to dysphagia and abdominal pain. Seventeen days earlier, the patient was quarantined because her daughter, a physician, was conformingly infected by SARS-CoV-2 and isolated at home. The patient started to have a fever, dry cough, and burning sensation in the nose. Her oxygen saturation had dropped rapidly during the following two days; therefore, she was treated with oxygen tanks at home with close follow-up by her daughter. For 15 days, the patient was treated with azithromycin (Zithromax). On the 18 th day, the patient's daughter sent us images for recent white patches inside her mouth ( Figure 1 ). On examining the intra-oral images, white membranous patches extended over labial mucosa, and soft palate and tongue dorsum were found. The patient was managed 

The authors declare that there is no conflict of interest.

The study was conducted according to the guidelines of the Declaration of Helsinki, and it was exempted from ethical approval due to its observational nature and the use of publicly accessible data. 

All the investigated patients agreed to use their clinical data for academic purposes while concealing their identifying personal data.

The data that support the findings of this study are available from the corresponding author upon reasonable request. 

Oral manifestations of COVID-19 disease: a review article

COVID-19-related oral manifestations: early disease features? Oral Dis

Oral complications of ICU patients with COVID-19: case-series and review of two hundred ten cases

Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?

Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact

Initial real-life experience from a designated COVID-19 centre in Athens, Greece: a proposed therapeutic algorithm

Oral manifestations in a patient with a history of asymptomatic COVID-19: case report

Oral manifestations associated with COVID-19

First neonates with severe acute respiratory syndrome coronavirus 2 infection in Romania

Oral candidiasis in non-severe COVID-19 patients: call for antibiotic stewardship. Oral Surg. 2020

Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility pattern

Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19

Prevalence of dry mouth in COVID-19 patients with and without Sicca syndrome in a large hospital center

The underestimated problem of oral Candida colonization-An observational pilot study in one nursing home